Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
VERO BEACH, Fla.–(BUSINESS WIRE)–Orchid Island Capital, Inc. (NYSE:ORC) (“Orchid” or the “Company”), a real estate investment trust (“REIT”), today announced that it will release results for the third quarter of 2023 following the close of trading on the New York Stock Exchange on Thursday, October 26, 2023.
Earnings Conference Call Details
An earnings conference call and live audio webcast will be hosted Friday, October 27, 2023, at 10:00 AM ET. The conference call may be accessed by dialing toll free (888) 510-2356. The conference ID is 8493186. A live audio webcast of the conference call can be accessed via the investor relations section of the Company’s website at www.orchidislandcapital.com, and an audio archive of the webcast will be available until November 26, 2023.
About Orchid Island Capital, Inc.
Orchid Island Capital, Inc. is a specialty finance company that invests on a leveraged basis in Agency RMBS. Our investment strategy focuses on, and our portfolio consists of, two categories of Agency RMBS: (i) traditional pass-through Agency RMBS, such as mortgage pass-through certificates issued by Fannie Mae, Freddie Mac or Ginnie Mae and CMOs, and (ii) structured Agency RMBS. Orchid is managed by Bimini Advisors, LLC, a registered investment adviser with the Securities and Exchange Commission.
Contacts
Orchid Island Capital, Inc.
Robert E. Cauley, 772-231-1400
Chairman and Chief Executive Officer
www.orchidislandcapital.com
Partner ecosystem built with technical integrations and validation from Nutanix, AWS, Red Hat OpenShift, HP,…
National award program recognizes innovative educators across preK-12, higher ed and post-graduate educationCOLUMBUS, Ohio--(BUSINESS WIRE)--Three…
Double board-certified facial plastic surgeon offers RADIESSE treatments at Laser & Cosmetic Surgery Specialists in…
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance…
ITHACA, NY / ACCESS Newswire / May 5, 2026 / GrammaTech will present four research…
Purchase orders position the Company to expand production and enable compliant, U.S.-based supply at scale…